Sentinel node lymphoscintigraphy in malignant melanoma

Nuclear Medicine Communications

Volumn 20, Issue 4, 1999, Pages 305-

  O'Doherty, M ^a   Nunan, T O ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HEAD AND NECK CANCER; HUMAN; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS; PATIENT MONITORING;

COLORING AGENTS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; RADIOPHARMACEUTICALS;

EID: 0032817221     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199904000-00003     Document Type: Article

References (7)

1. Reintgen D, Cruse W, Wells Ket al. The orderly progression of melanoma nodal métastasés. Ann Surg 1994; 220: 759-767.
2. Uren R, Howman-Giles R, Shaw H et al. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34: 1435-1440.
3. O’Brien C, Uren R, Thompson J et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170: 461-466.
4. Leong SPL, Steinmetz I, Habib F et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666-673.
5. Kapteijn BAE, Nieweg OE, Olmos Ret al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-975.
6. Reintgen D, Balch CM, Kirkwood J, Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997; 225: 1-14.
7. Thompson JF, McCarthy WH, Bosch C et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-260.